Tower Research Capital (TRC)’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-838
| Closed | -$19K | – | 6043 |
|
|
2020
Q4 | $19K | Sell |
838
-8,630
| -91% | -$196K | ﹤0.01% | 3920 |
|
|
2020
Q3 | $96K | Buy |
9,468
+5,241
| +124% | +$53.1K | ﹤0.01% | 3180 |
|
|
2020
Q2 | $63K | Buy |
4,227
+2,874
| +212% | +$42.8K | ﹤0.01% | 2877 |
|
|
2020
Q1 | $16K | Sell |
1,353
-2,853
| -68% | -$33.7K | ﹤0.01% | 1833 |
|
|
2019
Q4 | $67K | Buy |
+4,206
| New | +$67K | 0.01% | 1161 |
|
|
2019
Q3 | – | Sell |
-614
| Closed | -$8K | – | 4753 |
|
|
2019
Q2 | $8K | Buy |
+614
| New | +$8K | ﹤0.01% | 2732 |
|